Lisata Therapeutics, Inc. (LSTA)
3.22
-0.04
(-1.23%)
USD |
NASDAQ |
May 07, 16:00
3.22
0.00 (0.00%)
After-Hours: 20:00
Lisata Therapeutics Research and Development Expense (Annual) : 7.949M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Protalix Biotherapeutics, Inc. | 19.05M |
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| LadRx Corp. | 0.7727M |
| Plus Therapeutics, Inc. | 8.379M |